Today: 7 February 2026
Subscribe

Astera Labs (ALAB) Stock: Latest News, Analyst Forecasts, and Outlook (December 14, 2025)

Astera Labs (ALAB) Stock: Latest News, Analyst Forecasts, and Outlook (December 14, 2025)

Astera Labs (Nasdaq: ALAB) has seen sharp volatility in December. Here’s the latest news, Wall Street forecasts, and key catalysts investors are watching as of Dec. 14, 2025. ASTERA LABS, INC.+3StockAnalysis+3MarketBeat+3 Date: Sunday, December 14, 2025 (U.S. markets were closed; pricing reflects the most recent session). StockAnalysis+1 Astera Labs, Inc. (Nasdaq: ALAB) is back in the spotlight this weekend after a dramatic week of price swings and a fresh wave of commentary around AI data-center connectivity—especially how NVIDIA’s NVLink Fusion ecosystem and hyperscaler spending could reshape the interconnect landscape. StockAnalysis+2Business Insider+2 Below is a comprehensive, publication-ready roundup of the most
14 December 2025
·
Ripple Valuation Today (Dec. 14, 2025): Why Ripple Labs Is Being Priced Around $40 Billion—and What Could Move It Next

Ripple Valuation Today (Dec. 14, 2025): Why Ripple Labs Is Being Priced Around $40 Billion—and What Could Move It Next

Updated: December 14, 2025 Ripple Labs’ valuation has become one of the most closely watched numbers in crypto-fintech—partly because Ripple is still private, and partly because 2025 has turned into a turning point for regulated stablecoins, institutional custody, and bank-style charters. As of today (14/12/2025), the clearest, most widely reported benchmark for Ripple’s company valuation remains about $40 billion, anchored by a $500 million strategic investment announced in early November and a $1 billion tender offer earlier in 2025 at the same valuation, according to Reuters. Reuters In the last few days, Ripple’s valuation conversation has intensified again—this time not
14 December 2025
··
Arcus Biosciences (RCUS) Stock News, Forecasts and Analyst Targets — Dec. 14, 2025 Update

Arcus Biosciences (RCUS) Stock News, Forecasts and Analyst Targets — Dec. 14, 2025 Update

Arcus Biosciences, Inc. (NYSE: RCUS) is ending the weekend under a bright—and volatile—spotlight after a major clinical-program reset triggered a sharp Friday selloff. As of Sunday, December 14, 2025, the last reported close was $21.53, down 14.36% from the prior session, reflecting investor repricing after Arcus and partner Gilead halted a pivotal upper-GI cancer study. StockAnalysis What comes next for Arcus Biosciences stock now hinges less on TIGIT in gastric cancer and more on whether casdatifan can become a durable “anchor” asset in kidney cancer—and whether Arcus’ early move into inflammation and immunology can add long-dated upside without burning credibility
14 December 2025
Scale AI Valuation in 2025: Latest Read on the $29B Meta Deal, Private-Market Pricing Signals, and What Comes Next (Updated Dec. 14, 2025)

Scale AI Valuation in 2025: Latest Read on the $29B Meta Deal, Private-Market Pricing Signals, and What Comes Next (Updated Dec. 14, 2025)

As of December 14, 2025, one question keeps surfacing across venture circles, secondary-market platforms, and AI industry chatter: what is Scale AI actually worth right now? The most recent widely reported headline number still points to about $29 billion, tied to Meta’s blockbuster minority investment and expanded commercial relationship with Scale AI in mid‑2025. Scale AI+1But in the past several days, fresh reporting and updated private-market pricing signals have pulled that figure into a much more complicated—and much wider—range. This is not unusual for late-stage private companies, but Scale AI’s case is especially volatile because the company sits at the
14 December 2025
·
Sandisk (SNDK) Stock News Today: Downgrade Sparks Sharp Selloff, Analyst Price Targets, and 2026 Outlook (Dec. 14, 2025)

Sandisk (SNDK) Stock News Today: Downgrade Sparks Sharp Selloff, Analyst Price Targets, and 2026 Outlook (Dec. 14, 2025)

Published: Sunday, Dec. 14, 2025 (U.S. markets closed) Sandisk Corporation stock (NASDAQ: SNDK) heads into the Monday, Dec. 15 open with investors still digesting one of the biggest single-day drops among large-cap tech names this month—an abrupt reversal after a year defined by AI-driven enthusiasm, index inclusion, and a powerful memory-cycle rebound. Below is a complete, publication-ready roundup of today’s key headlines and context (Dec. 14, 2025), plus the latest analyst forecasts, price targets, and what to watch next. Sandisk stock price today: where SNDK stands on Dec. 14, 2025 Because today is Sunday, there is no regular-session trading in
14 December 2025
Oklo Inc. Stock (NYSE: OKLO) News, Forecasts and Analyst Outlook on Dec. 14, 2025 — ATM Offering, Sector Selloff, and What Investors Are Watching

Oklo Inc. Stock (NYSE: OKLO) News, Forecasts and Analyst Outlook on Dec. 14, 2025 — ATM Offering, Sector Selloff, and What Investors Are Watching

Updated: December 14, 2025 Oklo Inc. (NYSE: OKLO) is ending the week at the center of a familiar high-volatility trade: advanced nuclear power as a potential solution for AI-era electricity demand—and the equally familiar pushback investors deliver when dilution risk rises. As of the last U.S. market close (Friday, Dec. 12, 2025), Oklo shares finished at $87.42, down 15.13% on the day, following a sharp weekly slide that market commentary tied to weakness across uranium and nuclear-linked stocks. StockAnalysis+1 Below is a detailed, publication-ready breakdown of today’s most relevant Oklo stock news, current forecasts, and the leading analyst narratives shaping
14 December 2025
·
Modine Manufacturing Company (MOD) Stock Today: What’s Driving the Sell-Off, Fresh Analyst Targets, and 2026 Outlook (Dec. 14, 2025)

Modine Manufacturing Company (MOD) Stock Today: What’s Driving the Sell-Off, Fresh Analyst Targets, and 2026 Outlook (Dec. 14, 2025)

Modine Manufacturing Company (NYSE: MOD) stock is in the spotlight on December 14, 2025 after a sharp pullback that abruptly interrupted a powerful 2025 rally. With markets closed for the weekend, the latest available pricing reflects Friday’s close: MOD ended at $139.88, down 15.32% on the session, after trading in a wide range and resetting near the lower end of its recent band. Investing.com That sudden drop has triggered a wave of fresh “what just happened?” searches—especially because Modine has been one of the more closely watched industrial names tied to data center cooling demand. Below is a roundup of
14 December 2025
·
Anthropic Valuation 2025: Claude Maker’s $183B Price Tag Meets $300B+ Funding Talk as IPO Buzz Builds (Updated Dec. 14, 2025)

Anthropic Valuation 2025: Claude Maker’s $183B Price Tag Meets $300B+ Funding Talk as IPO Buzz Builds (Updated Dec. 14, 2025)

Anthropic—the AI company behind the Claude chatbot and Claude Code—has become one of the most watched private firms in tech, largely because its valuation is now being discussed in the same breath as the largest “frontier model” players on the planet. As of December 14, 2025, the most recently disclosed, official post‑money valuation for Anthropic remains $183 billion, set in its $13 billion Series F announced on September 2, 2025. Anthropic+1 But over the past two weeks, a rapid sequence of developments—IPO legal prep reports, new mega‑enterprise partnerships, an acquisition to bolster Claude Code, and fresh commentary questioning whether AI’s private valuations are “ahead of” public‑market reality—has intensified a
14 December 2025
Celestica Inc. Stock (CLS) Update: Why Shares Slumped, What Analysts Forecast, and the 2026 Outlook (Dec. 14, 2025)

Celestica Inc. Stock (CLS) Update: Why Shares Slumped, What Analysts Forecast, and the 2026 Outlook (Dec. 14, 2025)

Celestica Inc. (NYSE: CLS; TSX: CLS) is ending the week on a sharp down note after a steep tech-led selloff, even as new filings and fresh commentary published Sunday, Dec. 14, 2025 keep the company firmly in the spotlight for investors tracking AI data center infrastructure and hyperscaler spending. Below is a detailed, publication-ready look at today’s Celestica stock news, forecasts, and analysis, including what moved the shares, what Wall Street is modeling next, and the catalysts that could matter most into early 2026. Key takeaways for Celestica stock today Celestica stock price action: what happened into Dec. 14, 2025?
14 December 2025
··
Databricks Valuation Today (14/12/2025): $134B Fundraising Talk, $100B Baseline, and What Investors Watch Next

Databricks Valuation Today (14/12/2025): $134B Fundraising Talk, $100B Baseline, and What Investors Watch Next

Updated: December 14, 2025 (14/12/2025) Databricks has become one of the most closely watched private tech companies in the AI era—not because it builds chatbots, but because it sits underneath them. Its platform is where enterprises store, govern, process, and increasingly activate data for analytics and AI. That position at the center of “AI in production” is now showing up in the numbers investors care about most: valuation multiples, growth, and margin dynamics. Here’s the cleanest way to understand Databricks valuation today—what’s confirmed, what’s being reported, what secondary markets are signaling on December 14, 2025, and what could determine whether a rumored valuation
14 December 2025
xAI Valuation Today (Dec. 14, 2025): Why Elon Musk’s AI Startup Is Being Priced at $200B–$230B and What Comes Next

xAI Valuation Today (Dec. 14, 2025): Why Elon Musk’s AI Startup Is Being Priced at $200B–$230B and What Comes Next

Updated: December 14, 2025 Elon Musk’s xAI has become one of the most closely watched private companies in the AI boom—and for one reason above all: valuation. In recent weeks, reporting has pointed to a fresh fundraising push that could lift xAI’s implied worth to about $230 billion, a level that would place it among the most valuable private technology companies on Earth. Reuters But “xAI valuation” in late 2025 is not a single clean number. It’s a moving target shaped by a mix of reported financing terms, secondary-market trading, capital-intensive infrastructure buildout, and fast-evolving product distribution through X, Tesla, and new international
14 December 2025
··
SpaceX Valuation Surges to $800 Billion in Insider Share Sale—What the Latest IPO Forecasts Say for 2026 (Updated Dec. 14, 2025)

SpaceX Valuation Surges to $800 Billion in Insider Share Sale—What the Latest IPO Forecasts Say for 2026 (Updated Dec. 14, 2025)

SpaceX’s valuation has vaulted to a new headline number: about $800 billion, after an insider share sale was set at $421 per share—a price outlined in a Dec. 12 letter from Chief Financial Officer Bret Johnsen that was reviewed by Reuters. The arrangement allows new and existing investors (and SpaceX itself) to purchase up to $2.56 billion worth of shares from eligible shareholders, giving employees and insiders a fresh liquidity window while also resetting expectations for what SpaceX could command if it enters public markets. Reuters+2Reuters+2 The timing is not an accident. Over the past week, a tight cluster of reports—from secondary-sale chatter to IPO “target window” briefings—has turned SpaceX valuation into one
14 December 2025
·
OpenAI Valuation Today (Dec. 14, 2025): The $500 Billion Benchmark, $600B Secondary Signals, and the New Money Questions Investors Are Asking

OpenAI Valuation Today (Dec. 14, 2025): The $500 Billion Benchmark, $600B Secondary Signals, and the New Money Questions Investors Are Asking

December 14, 2025 — OpenAI’s valuation has become one of the most closely watched numbers in global tech, not because the company is public (it isn’t), but because the private market is now treating “the ChatGPT maker” like a bellwether for the entire AI economy. The headline valuation most investors still anchor to is $500 billion, set by a blockbuster employee share sale this fall. Reuters But in the past few weeks—and especially in the last few days—fresh signals have started to widen the conversation from “What is OpenAI worth?” to a sharper, more consequential question: What does OpenAI need to become worth even more—and
14 December 2025
·
Fermi Inc. (FRMI) Stock News Today: $150M Funding Deal Terminated, Project Matador Updates, and Analyst Price Targets (Dec. 14, 2025)

Fermi Inc. (FRMI) Stock News Today: $150M Funding Deal Terminated, Project Matador Updates, and Analyst Price Targets (Dec. 14, 2025)

December 14, 2025 — Fermi Inc. (NASDAQ: FRMI, LSE: FRMI) is in the spotlight after a dramatic selloff tied to a sudden change in its earliest tenant and financing narrative for Project Matador, the company’s flagship “behind-the-meter” power-and-data campus planned for West Texas. The drop has intensified debate over whether FRMI is a long-term AI-infrastructure winner trading at a steep discount—or a pre-revenue execution story facing its first major stress test. As of the most recent quote available heading into Sunday (markets closed), FRMI traded around $10.09 after a volatile week that included a heavy-volume plunge and a wide intraday
14 December 2025
RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

Published: Sunday, December 14, 2025 (U.S. markets last closed Friday, Dec. 12) RH (NYSE:RH)—the luxury home furnishings and lifestyle retailer—heads into the new week with investors digesting a busy stretch of catalysts: a fresh quarterly report, updated full‑year outlook, and a wave of analyst target changes that reshaped the near‑term narrative around tariffs, margin pressure, and a still‑sluggish housing backdrop. Reuters+1 On Friday, RH shares closed at $162.01, up roughly 5.7% on the day after the company’s results and outlook reset hit the tape late Thursday. StockAnalysis RH stock today: what changed heading into Dec. 14, 2025? The immediate catalyst
14 December 2025
··
CCC Intelligent Solutions Holdings Inc. Stock (NASDAQ: CCC): $500M Buyback, Debt-Funded ASR, Analyst Price Targets, and What’s Next (Dec. 14, 2025)

CCC Intelligent Solutions Holdings Inc. Stock (NASDAQ: CCC): $500M Buyback, Debt-Funded ASR, Analyst Price Targets, and What’s Next (Dec. 14, 2025)

CCC Intelligent Solutions Holdings Inc. shares are in focus this weekend after the company unveiled a major capital-return move that instantly reshaped the near‑term narrative around the stock: a fresh $500 million share repurchase authorization, anchored by a $300 million accelerated share repurchase (ASR) funded with new term-loan borrowings. SEC+1 Below is a detailed look at what’s new on Dec. 14, 2025, what Wall Street forecasts currently imply for upside/downside, and the operational and balance‑sheet factors investors are watching heading into the next earnings cycle. CCC stock today: price, range, and ticker clarity (CCC vs. “CCCS”) Because many headlines and
14 December 2025
·
Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets

Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets

Immunovant, Inc. (NASDAQ: IMVT) stock is closing out the week in focus after the company completed a major equity raise designed to bolster funding for its autoimmune pipeline—while its controlling shareholder, Roivant Sciences, stepped in as the largest buyer. As of the most recent market close ahead of Sunday, December 14, 2025, IMVT shares were around $26.42, up about 6.6% on the day, following heightened volatility and elevated trading activity during the week. Below is what changed, why it matters for investors tracking Immunovant stock, and how Wall Street-style consensus forecasts currently frame upside vs. risk. What’s driving Immunovant stock
14 December 2025
·
Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics (FOLD) Stock News, Forecasts and Analyst Outlook on Dec. 14, 2025: What’s Driving the Rally?

Amicus Therapeutics (NASDAQ: FOLD) is near a 52-week high after strong results and bullish analyst coverage. Here’s the latest news, forecasts, catalysts, and key risks as of Dec. 14, 2025. As of Sunday, December 14, 2025 (with U.S. markets closed), Amicus Therapeutics, Inc. (NASDAQ: FOLD) is finishing the week in the spotlight after a sharp move higher. The stock last traded around $10.55 on Friday, December 12, after climbing roughly 6.6% on the session and touching an intraday high of $10.85—a level that also marks the top end of its $5.51–$10.85 52‑week range. Yahoo Finance The late-week push has also
14 December 2025
·
lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

Lululemon (NASDAQ: LULU) stock is back in the spotlight after a Q3 earnings beat, updated fiscal 2025 guidance, a $1.0B buyback authorization increase, a CEO succession announcement, and confirmation it will be removed from the Nasdaq-100. Here’s what investors are watching as of December 14, 2025. lululemon athletica inc. stock (NASDAQ: LULU) has become one of the most talked-about retail names heading into the final stretch of 2025. The story is no longer just about athleisure demand—it’s about a leadership reset, a turnaround effort in the Americas, and index-related catalysts that could influence trading flows before year-end. Because December 14,
14 December 2025
·
EverCommerce (EVCM) Stock News, Analyst Forecasts, and Key Catalysts as of Dec. 14, 2025

EverCommerce (EVCM) Stock News, Analyst Forecasts, and Key Catalysts as of Dec. 14, 2025

Updated: December 14, 2025 EverCommerce Inc. (NASDAQ: EVCM) is back on many investors’ radar after a sharp rebound in December that pushed the stock near its 52‑week high—despite Wall Street remaining split on the company’s near‑term upside. As of December 14, 2025 (a Sunday, when U.S. markets are closed), EVCM last traded at $12.08 after Friday’s session (December 12), a move that capped a notable two‑week surge. StockAnalysis At the same time, the latest “instant alert” coverage dated December 14, 2025 highlights a “Hold” consensus from analysts, continued insider selling activity, and a wide dispersion in price targets—signals that the
14 December 2025
1 … 937 938 939 940 941 … 1,635

Stock Market Today

Go toTop